Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Deal Details

C/PIndustryStatusTicker(s)Issuer(s)Size(m)TranchesRegionDate
HYC
HLTH
PRCD
DOLCTH
Dolcetto Holdco SpA (Doc Pharma)€990
2EMEA
Jun 25, 2025
currency
EUR
size (m)
590.000
maturity
Jul 14, 2032
type
Fixed
tenor
7.000
call
3
registration
144A/Reg S
benchmark
-
ranking
Sr. Secured
moody's
B3
s&p
B
fitch
-
size description
-
re-open/tap
No
ipt
high 5s-6%
ipt-pxd
-
guidance
5.75% area (+/- 12.5bp); revised 5.625%-5.75%
spread
331
coupon
5.625%
spread set
-
price
100.00000
yield
5.625%
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
joint leads
passive leads
-
co-managers
-
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
joint leads
passive leads
-
co-managers
-
coordinating managers
-
currency
EUR
size (m)
400.000
maturity
Jul 14, 2032
type
Floating
tenor
7.000
call
1
registration
144A/Reg S
benchmark
-
ranking
Sr. Secured
moody's
B3
s&p
B
fitch
-
size description
-
re-open/tap
No
ipt
3mE+400bp area at par
ipt-pxd
-
guidance
E+375-400bp at par; Revised E+375bp area at par
spread
362.5
coupon
-
spread set
-
price
100.00000
yield
3mE+362.5bp
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
joint leads
passive leads
-
co-managers
-
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
joint leads
passive leads
-
co-managers
-
coordinating managers
-
Tranche Comments
Redemption: 2028-06-25; Registration: 144A/Reg S; Redemption: 2026-06-25; Registration: 144A/Reg S;
Deal Comments
Dolcetto Holdco SpA (DOC Pharma) (DOLCTH) EUR990m 144A/Reg S sr sec notes 2-part. B3/B (stable/stable). Via BNP (B&D)/Barc jt glocos/DB jt physical books/IMI/Mizuho/CA/KKR jt books. No reg rights. List Lux. NY law. Settles 07/14. - EUR590m (from EUR350m minimum) sr sec fixed-rate notes due 07/14/32 (7y). NC3 (06/25/28) (MWC B+50bp), then at 102.813, 101.406, 100. Equity claw: 3y 40% at 105.625. IPO claw: 4y 50% at 101. Special call: 10% per year the first 3 years at 103. CoC at 101. 30/360. Pays March 15 and Sept 15, starting 09/15/25 (30/360). Denoms: 100x1. Reg S ISIN: XS3106724241. IPT: high 5s-6%. Price talk: 5.75% area (+/- 12.5bp). Revised price talk: 5.625%-5.75%. Priced: 5.625% at 100. +331bp vs DBR 1.70% 08/15/32. - EUR400m (from EUR350m minimum) sr sec FRN due 07/14/32 (7y). NC1 (06/25/26) (MWC B+50bp), then at 100. CoC at 101. Pays March 15, June 15, Sept 15 and Dec 15, starting 09/15/25 (Actual/360). Denoms: 100x1. Reg S ISIN: XS73106723516. IPT: 3mE+400bp area at par. Price talk: E+375-400bp at par. Revised price talk: E+375bp area at par. Priced: 3mE+362.5bp at 100. Roadshow (1-on-1s) 06/23-25 (investor call at 1pm UKT 06/30). Books closed at 4:30pm UKT (from 3pm UKT) 06/25. UOP: repay $973m unitranche facility, GCP. Equity sponsors: TPG (804%), ICG (17.9%). Biz: leading Italian generic pharmaceutical company. Deal roadshow: https://dealroadshow.com/ Entry code: DOC25.

Commentary

Explore all other Commentary & Deal Flow

Deal Flow

Explore all other Commentary & Deal Flow
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.